Literature DB >> 21438959

Prosthodontic treatment of a class IV ACP PDI patient, with Langerhans cell histiocytosis (LCH).

George Papavasiliou1, Phophi Kamposiora, Alexandra Sklavounou, Panos Christopoulos.   

Abstract

Langerhans cell histiocytosis (LCH) is a disease of unknown etiology with a frustrating and unpredictable course. Surviving adult patients suffering from the multisystem type of the disease present with problems in most organs. This article presents the oral rehabilitation of a 28-year-old patient, with multisystem sequelae that included the oral cavity, classifying him as a Class IV American College of Prosthodontists Prosthodontic Diagnostic Index patient. A 5-year course of treatment is analyzed, starting from merely replacing missing teeth with a removable partial denture. The second stage of prosthetic rehabilitation included replacement of the removable prosthesis with fixed partial dentures. The final and most important aspect of treatment was the 2-year follow-up, when the patient presented with no problems or adverse effects. The purpose of this presentation is to offer an insight to prosthodontic treatment possibilities for patients suffering from multisystem LCH and to show the value of a "team approach" to achieving a positive outcome.
© 2011 by The American College of Prosthodontists.

Entities:  

Mesh:

Year:  2011        PMID: 21438959     DOI: 10.1111/j.1532-849X.2011.00702.x

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  1 in total

1.  Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature.

Authors:  Norbert Neckel; Andrej Lissat; Arendt von Stackelberg; Nadine Thieme; Mohemed-Salim Doueiri; Birgit Spors; Benedicta Beck-Broichsitter; Max Heiland; Jan-Dirk Raguse
Journal:  Ther Adv Med Oncol       Date:  2019-10-19       Impact factor: 8.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.